Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Total Liabilities (2017 - 2025)

Selectis Health's Total Liabilities history spans 13 years, with the latest figure at $38.9 million for Q3 2025.

  • For Q3 2025, Total Liabilities changed 0.4% year-over-year to $38.9 million; the TTM value through Sep 2025 reached $38.9 million, changed 0.4%, while the annual FY2024 figure was $38.9 million, 10.95% down from the prior year.
  • Total Liabilities for Q3 2025 was $38.9 million at Selectis Health, down from $40.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $44.1 million in Q2 2023 and bottomed at $38.8 million in Q3 2024.
  • The 5-year median for Total Liabilities is $42.4 million (2022), against an average of $41.8 million.
  • The largest annual shift saw Total Liabilities grew 5.53% in 2021 before it fell 10.95% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $43.8 million in 2021, then dropped by 5.21% to $41.5 million in 2022, then grew by 5.05% to $43.6 million in 2023, then fell by 10.95% to $38.9 million in 2024, then rose by 0.15% to $38.9 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Total Liabilities are $38.9 million (Q3 2025), $40.0 million (Q2 2025), and $40.6 million (Q1 2025).